Skip to main content

Filterlex is a unique, full-body, embolic protection device for Trans-catheter Aortic Valve Implantation procedures.

Project description

A protective device against embolism

Aortic valve diseases may require surgical replacement of the defective valve. This is often performed through a procedure known as transcatheter aortic valve implantation (TAVI), which involves the insertion of a catheter into a blood vessel to reach the heart and fix the valve. However, TAVI carries the risk of releasing embolic particles from the natural aortic valve to the blood flow which can reach the brain or other organs, with debilitating consequences. The key objective of the EU-funded Filterlex project is to prevent such complications and reduce the risk of stroke during catheter-based structural heart procedures. To that end, the project has developed a protective device that is placed on the aorta during the TAVI procedure to capture and remove embolic particles.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

FILTERLEX MEDICAL LTD
Net EU contribution
€ 50 000,00
Address
Tavor Building Yokneam
20692 Yokneam
Israel

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00